Complement as a Natural Adjuvant to Promote Anti-Tumor Immunity in Cancer Therapy

Time: 12:00 pm
day: Day Two


  • Exploring how the complement system interacts with the tumor microenvironment in driving anti-tumor immunity in cancer
  • Human-derived antibodies can cause complement activation, tumor-specific cytotoxicity, and anti-tumor immunity
  • Evaluating implications for metrics in measuring success of complement therapy in cancer, and subsequent novel trial design